Supernus Pharmaceuticals | SUPN - Ebitda





Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Aurora Cannabis CAD 18.48M 3.11M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Canopy Growth CAD -2.87M 19.49M 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Eisai JPY -335M 30.43B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Novo Nordisk DKK 34.72B 2.57B 2026-03
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
United Therapeutics USD 379.5M 83.4M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12